GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+12.3%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$383M
AUM Growth
+$383M
(+8.9%)
Cap. Flow
+$15.6M
Cap. Flow
% of AUM
4.07%
Top 10 Holdings %
Top 10 Hldgs %
62.79%
Holding
52
New
12
Increased
8
Reduced
12
Closed
10
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$44.1M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$19.1M |
| 3 |
argenx
ARGX
|
$14.2M |
| 4 |
Axsome Therapeutics
AXSM
|
$13.9M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$12.7M |
Top Sells
| 1 |
Iovance Biotherapeutics
IOVA
|
$24.5M |
| 2 |
Ascendis Pharma
ASND
|
$18.4M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$14.7M |
| 4 |
Travere Therapeutics
TVTX
|
$11.3M |
| 5 |
AnaptysBio
ANAB
|
$8.4M |
Sector Composition
| 1 | Healthcare | 91.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sarepta Therapeutics
SRPT
$1.78B
| $44.1M | 9.14% | +290,000 | New | +$44.1M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $35.4M | 7.34% | 375,000 +135,000 | +56% | +$12.7M |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $34.5M | 7.16% | 335,000 +185,000 | +123% | +$19.1M |
|
|
4
Ascendis Pharma
ASND
$11.8B
| $25.9M | 5.37% | 225,000 -160,000 | -42% | -$18.4M |
|
|
5
Axsome Therapeutics
AXSM
$6.05B
| $21.9M | 4.54% | 850,000 +540,000 | +174% | +$13.9M |
|
6
Acadia Pharmaceuticals
ACAD
$4.38B
| $20M | 4.16% | 750,000 -150,000 | -17% | -$4.01M |
|
7
Amicus Therapeutics
FOLD
$2.34B
| $18.1M | 3.75% | 1,450,000 +150,000 | +12% | +$1.87M |
|
|
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $15.8M | 3.27% | 300,000 | – | – |
|
|
9
argenx
ARGX
$43.6B
| $14.2M | 2.94% | +100,000 | New | +$14.2M |
|
10
Alnylam Pharmaceuticals
ALNY
$58.5B
| $10.9M | 2.26% | 150,000 | – | – |
|
11
BioCryst Pharmaceuticals
BCRX
$1.74B
| $9.48M | 1.97% | 2,500,000 +2,000,000 | +400% | +$7.58M |
|
|
RARX
12
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $9.02M | 1.87% | 300,000 | – | – |
|
13
Invesco CurrencyShares Swiss Franc Trust
FXF
$376M
| $8.75M | 1.82% | 92,200 +400 | +0.4% | +$38K |
|
|
IMMU
14
DELISTED
Immunomedics Inc
IMMU
| $8.32M | 1.73% | 600,000 -200,000 | -25% | -$2.77M |
|
|
CBAY
15
DELISTED
Cymabay Therapeutics
CBAY
| $7.16M | 1.49% | 1,000,000 +250,000 | +33% | +$1.79M |
|
16
Rocket Pharmaceuticals
RCKT
$354M
| $6.9M | 1.43% | 460,000 -140,000 | -23% | -$2.1M |
|
17
KalVista Pharmaceuticals
KALV
$678M
| $6.65M | 1.38% | 300,000 -100,000 | -25% | -$2.22M |
|
|
VRAY
18
DELISTED
ViewRay, Inc.
VRAY
| $6.61M | 1.37% | 750,000 | – | – |
|
19
Milestone Pharmaceuticals
MIST
$156M
| $6.52M | 1.35% | +240,000 | New | +$6.52M |
|
|
MNTA
20
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $6.23M | 1.29% | 500,000 | – | – |
|
21
Zymeworks
ZYME
$1.12B
| $6.05M | 1.25% | +275,000 | New | +$6.05M |
|
|
EPZM
22
DELISTED
Epizyme, Inc
EPZM
| $5.84M | 1.21% | 465,000 -35,000 | -7% | -$439K |
|
|
SAGE
23
DELISTED
Sage Therapeutics
SAGE
| $5.49M | 1.14% | 30,000 -45,000 | -60% | -$8.24M |
|
|
ONCE
24
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $5.12M | 1.06% | +50,000 | New | +$5.12M |
|
25
Arvinas
ARVN
$568M
| $4.95M | 1.03% | 225,000 +50,000 | +29% | +$1.1M |
|